Building the Future of Oncology Innovation. Join Campus Grand Parc!

Are you an oncology startup looking for the right ecosystem to grow? A pharma company or investor seeking access to cutting-edge innovation in oncology?

Join the Paris-Saclay Cancer Cluster (PSCC) at Campus Grand Parc- Europe’s premier hub for accelerating cancer innovation.

In 2025, Campus Grand Parc will offer an initial 45,000 m2 of infrastructure dedicated to biotech companies, mid-size and large pharmaceutical companies, CROs, CDMOs, and clinical experts. By 2032, this will expand to 100,000 m2, fostering a dynamic environment for innovation and collaboration.

As the core of the PSCC ecosystem, it brings together researchers, clinicians, industry leaders, entrepreneurs, investors, and patients to translate scientific advancements into industrial, therapeutic, and diagnostic solutions.

A thriving collaborative environment

?? Since January 2025, the PSCC has firmly established itself in Lab116, at the heart of Campus Grand Parc, a site adjacent to Gustave Roussy, Europe’s leading cancer center, and in close proximity to renowned EU institutions such as Institut Curie and AP-HP. The new campus facilities provide convenient access to cutting-edge technology and clinical platforms, office space, laboratories, CROs, CDMOs, VCs, as well as scientific, clinical, and industrial experts, fostering enhanced on-site networking.

Additionally, hosting all PSCC events, including 'Jeudi' and 'Petits Déjeuners', on the cluster will further strengthen collaboration within the community.

A tailored real estate offering

Whether you are a fast-growing startup, an established biotech, a pharmaceutical company, a CRO or an investor, the Campus - developed by leading real estate and infrastructure players - offers a wide range of office and laboratory spaces of various sizes, along with shared facilities, ensuring optimal solutions and controlled investment.

The Campus also offers dedicated meeting and event spaces to drive collaboration. With direct access to advanced technological and clinical platforms, (?? Scientific Offer of the PSCC: High-level Technology Platforms | LinkedIn), it stands as a strategic hub for oncology innovators.

?? Three buildings with 45,000 m2 of available space by 2025

? Lab 116 (Perelis) - The first operational building on site: 7,000 m2 of office and lab space.

? Byos (Amundi) - Opening mid-2025: 15,000 m2 of office space.

? The Hive (Kadans) - Opening late 2025: 24,500 sqm of office and lab space of various sizes, including specialized infrastructure (labs, central lab, innovation center, equipment and dedicated teams), coworking spaces and meeting rooms.

For more information or to get in touch with real estate operators, please visit the 'Contact' page on the Campus Grand Parc website https://www.campusgrandparc.com/fr _or reach out through our PSCC website: https://www.parissaclaycancercluster.org/campus-grand-parc

A world-class, well-connected hub

Campus Grand Parc benefits from outstanding connectivity, with the recent opening of the Villejuif – Gustave Roussy station on Metro Line 14. Paris city center (Chatelet) is just 20 minutes away, Gare de Lyon 15 minutes and Orly Airport only 10 minutes. This strategic location makes it an ideal hub for international talent while ensuring seamless access for patients and their families.

?? Explore the Campus Grand Parc website to learn more:

Campus Grand Parc: an eco-district dedicated to medical research in Villejuif

A global vision to drive oncology innovation forward

"Our vision for Campus Grand Parc is to create a thriving hub for oncological innovation, combining world-class infrastructure with a dynamic ecosystem " explains Benjamin Garel, CEO of the PSCC. “We are fostering a vibrant community where startups connect, collaborate, and grow. With regular events and networking opportunities, we are actively building the collective energy that fuels innovation.”

“With cutting-edge labs, office spaces, and advanced research platforms, we provide the strategic resources needed to accelerate R&D and turn scientific breakthroughs into real-world treatments.”

The PSCC's mission is clear: to create the optimal conditions for accelerating the development of innovative solutions against cancer. By doing so, it aims to transform the lives of millions of patients worldwide while positioning France and Europe as global leaders in oncology innovation.

?? Sign up for our newsletter to get the latest updates!

And visit our website to learn more: ?? https://www.parissaclaycancercluster.org/

Thank you for your interest and support in the Paris-Saclay Cancer Cluster.

?? By becoming part of this vibrant environment, you will join a community united by a shared mission: advancing research and accelerating innovation in the fight against cancer.

#PSCCInsights #PSCC #CancerResearch #InnovationAgainstCancer #StayInformed #CampusGrandParc #Biotech #Healthcare #Oncology